| FDA NEWS FDA approves Movantik for opioid-induced constipation Meet the newest FDA-approved prescription weight-loss drug: Contrave |
 |
Maker of Costly Hepatitis C Drug Sovaldi Strikes Deal on Generics for Poor Countries
New York Times - September 15, 2014
The maker of one of the costliest drugs in the world announced on Monday that it had struck deals with seven generic drug makers in India to sell lower-cost versions of the medicine — a $1,000-a-pill hepatitis C treatment — in poorer countries.
Kaiser: 2014 Employer Health Benefits Survey
Kaiser Family Foundation - September 10, 2014
Employer-sponsored insurance covers about 149 million nonelderly people. To provide current information about employer-sponsored health benefits, the Kaiser Family Foundation (Kaiser) and the Health Research & Educational Trust (HRET) conduct an annual survey of private and nonfederal public employers with three or more workers. This is the sixteenth Kaiser/HRET survey and reflects employer-sponsored health benefits in 2014.
Hospitals waste millions on antibiotics
Healthcare Finance News - September 18, 2014
Potential cases of antibiotics misuse add up to nearly $13 million in estimated excess costs for hospitals.
Hospitals and Insurer Join Forces in California
New York Times - September 17, 2014
In a partnership that appears to be the first of its kind, Anthem Blue Cross, a large California health insurance company, is teaming up with seven fiercely competitive hospital groups to create a new health system in the Los Angeles area. The partnership includes such well-known medical centers as UCLA Health and Cedars-Sinai.
New drug formulations to boost fight against respiratory illnesses, antibiotic-resistant superbugs
ScienceDaily - September 16, 2014
Antibiotic resistance is a challenge in the treatment of diseases today as bacteria continuously mutate and develop resistance against multiple drugs designed to kill them, turning them into superbugs. New ways to enhance the efficacy of drugs used to treat respiratory system infections and antibiotic-resistant superbugs have now been uncovered by researchers.
Can the ACA Solve Staggering Prescription Drug Prices?
California Healthline - August 20, 2014
The Affordable Care Act (ACA) does have several provisions that seek to control costs, but none of them relate to prescription drug pricing. And while lawmakers for years have suggested that the federal government be allowed to negotiate prices on behalf of Medicare beneficiaries, no such provision made it into the ACA.
Drug Safety Report Details 49,000 Undisclosed Side Effect Reports
Drug Discovery & Development - September 10, 2014
AdverseEvents Inc., a healthcare informatics company, released a special report titled "Expediting Drug Safety Using FOIA: An Analysis of 48,971 Unreleased FAERS Reports," at TEDMED 2014 in San Francisco, California.
Study: Rare Blood Type May Slightly Raise Dementia Risk
HealthDay News - September 10, 2014
Your blood type may play a small role in your risk for dementia, a new study finds.
Sticking Point: The Price of an Old Insulin Skyrockets
Wall Street Journal - September 11, 2014
Insulin is an old drug, but the price of one of its most concentrated formulations – known as Humulin U-500 – increased more than five times over the last seven years. In 2007, the wholesale cost for a one-month supply was about $220, but is now approximately $1,200, according to MedPage Today.
Fat Chance? Novo Hopes to Sell its Injectable Diabetes Med as a Diet Drug
Wall Street Journal - September 10, 2014
Can an injectable diabetes drug make a successful transition into a big-selling fat fighter?
Osteoporosis Drugs Work, But Review Finds No Clear Winner
Health Day - September 8, 2014
Many osteoporosis drugs cut women's risk of suffering a bone fracture, though it's not clear whether any one medication works better than others, a new research review finds.
Contact,
Kristin LaVitola
Marketing Director, PSG
Pharmaceutical Strategies Group (PSG)
Office: 972-244-8388
Email: KLavitola@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |